Open AccessFDA Approves Xalkori (Crizotinib) for NSCLC
Publication year - 2013
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000441844.95548.78
Subject(s) - crizotinib , medicine , oncology , lung cancer , malignant pleural effusion